Axios @axios
The Biden administration unveiled three drug payment programs Tuesday aimed at helping reduce patients' out-of-pocket costs. One would potentially lower Medicare payments for promising treatments approved by the FDA before clinical trials are complete. https://t.co/paaJDZzMFX — PolitiTweet.org